Taros, a privately owned CRO has been serving pharmaceutical, biotech and chemical companies since 1999. Within our drug discovery division, our mission is to accelerate potential new medicines into clinical development. Taros adds considerable value to drug discovery collaborations to boost collaborators’ discovery programs from target validation and hit identification to lead generation and optimization.
Taros’ capabilities include medicinal chemistry, computational sciences and innovative compound libraries. Taros has been leading the chemistry activities of the European Lead Factory (ELF), EU’s 196 million EUR early drug discovery platform, and currently is involved in the 11 million EUR “Drug Discovery Hub Dortmund”.
For more information, please visit www.taros.de